Filing Details

Accession Number:
0001613103-24-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-23 17:18:46
Reporting Period:
2024-02-21
Accepted Time:
2024-02-23 17:18:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1792380 Sean Salmon 710 Medtronic Parkway
Minneapolis MN 55432
Evp & President Cardiovascular No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2024-02-21 1,594 $62.76 49,833 No 4 M Direct
Ordinary Shares Acquisiton 2024-02-21 13,066 $62.76 62,949 No 4 M Direct
Ordinary Shares Acquisiton 2024-02-21 16,035 $74.84 78,984 No 4 M Direct
Ordinary Shares Disposition 2024-02-21 1,594 $85.06 77,390 No 4 S Direct
Ordinary Shares Disposition 2024-02-21 13,066 $85.15 64,324 No 4 S Direct
Ordinary Shares Disposition 2024-02-21 16,035 $85.12 48,289 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2024-02-21 1,594 $0.00 1,594 $62.76
Ordinary Shares Stock Option (Right to Buy) Disposition 2024-02-21 13,066 $0.00 13,066 $62.76
Ordinary Shares Stock Option (Right to Buy) Disposition 2024-02-21 16,035 $0.00 16,035 $74.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,066 2015-07-28 2024-07-28 No 4 M Direct
0 2015-07-28 2024-07-28 No 4 M Direct
0 2016-01-27 2025-01-27 No 4 M Direct
Footnotes
  1. Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person.
  2. The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
  3. The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.